Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 9.83 | 48.18 |
| PEG Ratio (TTM) | 2.15 | 8.37 |
| P/S Ratio (TTM) | 4.06 | 16.43 |
| P/B Ratio (TTM) | 7.17 | 17.03 |
| P/FCF Ratio (TTM) | 25.97 | 49.79 |
| Price to 5YR AVG Earnings Ratio | N/A | 12.66 |
| Price to 5YR AVG FCF Ratio | N/A | 56.19 |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 12.82% | 12.25% |
| ROE (TTM) | 78.97% | 58.56% |
| Net Profit Margin (TTM) | 41.28% | 24.30% |
| ROIC 5YR AVG | N/A | -19.11% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.68% | 45.20% | N/A |
| Revenue | 7.06% | 33.94% | N/A |
| Net Income | 4.65% | 45.21% | N/A |
| Cash Flow | 120.68% | 420.89% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.98 | 1.60 |
| Quick Ratio (TTM) | 0.98 | 1.59 |
| D/E Ratio (TTM) | 0.12 | 0.92 |
| Interest Coverage (TTM) | 9.20 | 56.25 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 1.11 | 12.19 |
| LTL to 5YR AVG FCF | N/A | 5.14 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.47% |